APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Inactive Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Swine Inactive Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025187 pages

Choose your research edition.

Industry ResearchSwine Inactive Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Inactive Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Swine Inactive Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Inactive Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Inactive Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Swine Inactive Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Inactive Vaccine include Zhongmu Industry, Wuhan Keqian Biology, Shenzhen BIOCBD Biotechnology, Shenlian Biomedical, Qindao Lijian Bio-Tech, Jinyu Biotechnology, Harbin Pharmaceutical Group Bio-vaccine, DHN and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Inactive Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Inactive Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Inactive Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Inactive Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Inactive Vaccine Segment by Company

Zhongmu Industry

Wuhan Keqian Biology

Shenzhen BIOCBD Biotechnology

Shenlian Biomedical

Qindao Lijian Bio-Tech

Jinyu Biotechnology

Harbin Pharmaceutical Group Bio-vaccine

DHN

Boehringer Ingelheim

Swine Inactive Vaccine Segment by Type

Haemophilus Parasuis Vaccine

Porcine Circovirus Type 2 Vaccine

Mycoplasma Hyopneumoniae Bacterin Vaccine

Others

Swine Inactive Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Inactive Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Inactive Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Inactive Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Inactive Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Inactive Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Inactive Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Inactive Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Inactive Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Inactive Vaccine Industry Trends Table 2. Swine Inactive Vaccine Industry Drivers Table 3. Swine Inactive Vaccine Industry Opportunities and Challenges Table 4. Swine Inactive Vaccine Industry Restraints Table 5. Global Swine Inactive Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Inactive Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Inactive Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Swine Inactive Vaccine Sales Market Share by Manufacturers Table 9. Global Swine Inactive Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Swine Inactive Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Inactive Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Inactive Vaccine Manufacturers, Product Type & Application Table 13. Global Swine Inactive Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Inactive Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Haemophilus Parasuis Vaccine Table 17. Major Manufacturers of Porcine Circovirus Type 2 Vaccine Table 18. Major Manufacturers of Mycoplasma Hyopneumoniae Bacterin Vaccine Table 19. Major Manufacturers of Others Table 20. Global Swine Inactive Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Swine Inactive Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Swine Inactive Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Swine Inactive Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Swine Inactive Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Swine Inactive Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Swine Inactive Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Swine Inactive Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Swine Inactive Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Swine Inactive Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Breeding Farm Table 31. Major Manufacturers of Veterinary Clinic Table 32. Global Swine Inactive Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Swine Inactive Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Swine Inactive Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Swine Inactive Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Swine Inactive Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Swine Inactive Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Swine Inactive Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Swine Inactive Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Swine Inactive Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Swine Inactive Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Swine Inactive Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Swine Inactive Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Swine Inactive Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Swine Inactive Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Swine Inactive Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Swine Inactive Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Swine Inactive Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Swine Inactive Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Swine Inactive Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Swine Inactive Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Swine Inactive Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Swine Inactive Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Swine Inactive Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Swine Inactive Vaccine Revenue Market Share by Region (2027-2032) Table 64. Zhongmu Industry Company Information Table 65. Zhongmu Industry Business Overview Table 66. Zhongmu Industry Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhongmu Industry Swine Inactive Vaccine Product Portfolio Table 68. Zhongmu Industry Recent Development Table 69. Wuhan Keqian Biology Company Information Table 70. Wuhan Keqian Biology Business Overview Table 71. Wuhan Keqian Biology Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio Table 73. Wuhan Keqian Biology Recent Development Table 74. Shenzhen BIOCBD Biotechnology Company Information Table 75. Shenzhen BIOCBD Biotechnology Business Overview Table 76. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio Table 78. Shenzhen BIOCBD Biotechnology Recent Development Table 79. Shenlian Biomedical Company Information Table 80. Shenlian Biomedical Business Overview Table 81. Shenlian Biomedical Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shenlian Biomedical Swine Inactive Vaccine Product Portfolio Table 83. Shenlian Biomedical Recent Development Table 84. Qindao Lijian Bio-Tech Company Information Table 85. Qindao Lijian Bio-Tech Business Overview Table 86. Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio Table 88. Qindao Lijian Bio-Tech Recent Development Table 89. Jinyu Biotechnology Company Information Table 90. Jinyu Biotechnology Business Overview Table 91. Jinyu Biotechnology Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio Table 93. Jinyu Biotechnology Recent Development Table 94. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 95. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 96. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio Table 98. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 99. DHN Company Information Table 100. DHN Business Overview Table 101. DHN Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. DHN Swine Inactive Vaccine Product Portfolio Table 103. DHN Recent Development Table 104. Boehringer Ingelheim Company Information Table 105. Boehringer Ingelheim Business Overview Table 106. Boehringer Ingelheim Swine Inactive Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio Table 108. Boehringer Ingelheim Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Swine Inactive Vaccine Distributors List Table 112. Swine Inactive Vaccine Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Swine Inactive Vaccine Product Image Figure 2. Global Swine Inactive Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Inactive Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Inactive Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Swine Inactive Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Inactive Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Haemophilus Parasuis Vaccine Image Figure 9. Porcine Circovirus Type 2 Vaccine Image Figure 10. Mycoplasma Hyopneumoniae Bacterin Vaccine Image Figure 11. Others Image Figure 12. Global Swine Inactive Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Swine Inactive Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Swine Inactive Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Swine Inactive Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Swine Inactive Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Swine Inactive Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Breeding Farm Image Figure 19. Veterinary Clinic Image Figure 20. Global Swine Inactive Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Swine Inactive Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Swine Inactive Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Swine Inactive Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Swine Inactive Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Swine Inactive Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Swine Inactive Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Swine Inactive Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Swine Inactive Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Swine Inactive Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Swine Inactive Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Swine Inactive Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Swine Inactive Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Swine Inactive Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Swine Inactive Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Swine Inactive Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Swine Inactive Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Swine Inactive Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Swine Inactive Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Haemophilus Parasuis Vaccine
  • Porcine Circovirus Type 2 Vaccine
  • Mycoplasma Hyopneumoniae Bacterin Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Zhongmu Industry
  • Wuhan Keqian Biology
  • Shenzhen BIOCBD Biotechnology
  • Shenlian Biomedical
  • Qindao Lijian Bio-Tech
  • Jinyu Biotechnology
  • Harbin Pharmaceutical Group Bio-vaccine
  • DHN
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Inactive Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Inactive Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Inactive Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Inactive Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Inactive Vaccine Market Dynamics
  1. 2.1 Swine Inactive Vaccine Industry Trends
  2. 2.2 Swine Inactive Vaccine Industry Drivers
  3. 2.3 Swine Inactive Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Inactive Vaccine Industry Restraints
3 Swine Inactive Vaccine Market by Manufacturers
  1. 3.1 Global Swine Inactive Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Inactive Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Inactive Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Inactive Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Inactive Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Inactive Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Swine Inactive Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Inactive Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Inactive Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Inactive Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Inactive Vaccine Market by Type
  1. 4.1 Swine Inactive Vaccine Type Introduction
  2. 4.1.1 Haemophilus Parasuis Vaccine
  3. 4.1.2 Porcine Circovirus Type 2 Vaccine
  4. 4.1.3 Mycoplasma Hyopneumoniae Bacterin Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Swine Inactive Vaccine Sales by Type
  7. 4.2.1 Global Swine Inactive Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Swine Inactive Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Swine Inactive Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Swine Inactive Vaccine Revenue by Type
  11. 4.3.1 Global Swine Inactive Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Swine Inactive Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Swine Inactive Vaccine Revenue Market Share by Type (2021-2032)
5 Swine Inactive Vaccine Market by Application
  1. 5.1 Swine Inactive Vaccine Application Introduction
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Inactive Vaccine Sales by Application
  5. 5.2.1 Global Swine Inactive Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Inactive Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Swine Inactive Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Swine Inactive Vaccine Revenue by Application
  9. 5.3.1 Global Swine Inactive Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Inactive Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Swine Inactive Vaccine Revenue Market Share by Application (2021-2032)
6 Global Swine Inactive Vaccine Sales by Region
  1. 6.1 Global Swine Inactive Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Inactive Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Inactive Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Inactive Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Inactive Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Inactive Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Inactive Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Inactive Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Inactive Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Inactive Vaccine Revenue by Region
  1. 7.1 Global Swine Inactive Vaccine Revenue by Region
  2. 7.1.1 Global Swine Inactive Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Inactive Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Inactive Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Inactive Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Inactive Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Inactive Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Inactive Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Inactive Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Inactive Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongmu Industry
  2. 8.1.1 Zhongmu Industry Company Information
  3. 8.1.2 Zhongmu Industry Business Overview
  4. 8.1.3 Zhongmu Industry Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhongmu Industry Swine Inactive Vaccine Product Portfolio
  6. 8.1.5 Zhongmu Industry Recent Developments
  7. 8.2 Wuhan Keqian Biology
  8. 8.2.1 Wuhan Keqian Biology Company Information
  9. 8.2.2 Wuhan Keqian Biology Business Overview
  10. 8.2.3 Wuhan Keqian Biology Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio
  12. 8.2.5 Wuhan Keqian Biology Recent Developments
  13. 8.3 Shenzhen BIOCBD Biotechnology
  14. 8.3.1 Shenzhen BIOCBD Biotechnology Company Information
  15. 8.3.2 Shenzhen BIOCBD Biotechnology Business Overview
  16. 8.3.3 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio
  18. 8.3.5 Shenzhen BIOCBD Biotechnology Recent Developments
  19. 8.4 Shenlian Biomedical
  20. 8.4.1 Shenlian Biomedical Company Information
  21. 8.4.2 Shenlian Biomedical Business Overview
  22. 8.4.3 Shenlian Biomedical Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shenlian Biomedical Swine Inactive Vaccine Product Portfolio
  24. 8.4.5 Shenlian Biomedical Recent Developments
  25. 8.5 Qindao Lijian Bio-Tech
  26. 8.5.1 Qindao Lijian Bio-Tech Company Information
  27. 8.5.2 Qindao Lijian Bio-Tech Business Overview
  28. 8.5.3 Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio
  30. 8.5.5 Qindao Lijian Bio-Tech Recent Developments
  31. 8.6 Jinyu Biotechnology
  32. 8.6.1 Jinyu Biotechnology Company Information
  33. 8.6.2 Jinyu Biotechnology Business Overview
  34. 8.6.3 Jinyu Biotechnology Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio
  36. 8.6.5 Jinyu Biotechnology Recent Developments
  37. 8.7 Harbin Pharmaceutical Group Bio-vaccine
  38. 8.7.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  39. 8.7.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  40. 8.7.3 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio
  42. 8.7.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  43. 8.8 DHN
  44. 8.8.1 DHN Company Information
  45. 8.8.2 DHN Business Overview
  46. 8.8.3 DHN Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DHN Swine Inactive Vaccine Product Portfolio
  48. 8.8.5 DHN Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Swine Inactive Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Inactive Vaccine Value Chain Analysis
  2. 9.1.1 Swine Inactive Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Inactive Vaccine Production Mode & Process
  6. 9.2 Swine Inactive Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Inactive Vaccine Distributors
  9. 9.2.3 Swine Inactive Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst